Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 29,717 | 26,969 | 30,302 | 22,386 | 19,150 |
| Operating Income | -29,717 | -26,969 | -30,302 | -22,386 | -19,150 |
| Other Income | 462 | 444 | 720 | 465 | 130 |
| Pre-tax Income | -29,255 | -26,525 | -29,582 | -21,921 | -19,020 |
| Net Income Continuous | -29,255 | -26,525 | -29,582 | -21,921 | -19,020 |
| Net Income | $-29,255 | $-26,525 | $-29,582 | $-21,921 | $-19,020 |
| EPS Basic Total Ops | -10.05 | -11.39 | -12.74 | -9.60 | -8.25 |
| EPS Basic Continuous Ops | -10.09 | -11.41 | -12.75 | -9.52 | -8.26 |
| EPS Diluted Total Ops | -10.05 | -11.39 | -12.74 | -9.60 | -8.25 |
| EPS Diluted Continuous Ops | -10.09 | -11.41 | -12.75 | -9.52 | -8.26 |
| EBITDA(a) | $-28,964 | $-26,398 | $-29,854 | $-21,943 | $-18,623 |